GlassScriptPhysician profile
Jinu J John
NPI 1467682369
$12,129.45
in general payments reported to CMS, 2019-2025
10 companies · $451 in 2025
The $451 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,437 · 2020: $133 · 2021: $137 · 2022: $1,846 · 2023: $726 · 2024: $3,401 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,638 · Food and Beverage: $1,939.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,637.74 |
| Food and Beverage | $1,939.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $9,589.31 | 2019-2025 | Aveir, Amplatzer Amulet, Merlin@Home |
| Boston Scientific Corporation | $1,776.76 | 2019-2025 | Watchman Flx, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Biotronik INC. | $265.89 | 2022 | |
| Biosense Webster, INC. | $258.45 | 2020-2024 | Qdot Micro Catheter |
| Medtronic, INC. | $107.11 | 2024-2025 | Omniasecure Mri Surescan, Corevalve Evolut R |
| Novartis Pharmaceuticals Corporation | $64.11 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $28.04 | 2024 | Wainua |
| Medtronic Vascular, INC. | $15.24 | 2019 | |
| Cardiva Medical, INC. | $15.21 | 2021 | |
| Altathera Pharmaceuticals LLC | $9.33 | 2024 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jinu John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.